Graid Technology Inc. and KLC Group Forge Groundbreaking Partnership to Redefine High-Speed RAID and Data-at-Rest Security
Protecting enterprise and military servers with unmatched NVMe RAID performance and the most advanced cybersecurity encryption on the market.
SANTA CLARA, CA / ACCESSWIRE / October 1, 2024 / As data demands surge in today's hyper-competitive landscape, organizations are constantly seeking solutions that balance cutting-edge security with uncompromised performance. A new strategic partnership between Graid Technology, creators of SupremeRAID™, and KLC Group, innovators behind CipherDriveOne Plus, is set to redefine this balance with a first-of-its-kind solution for high-speed storage and NSA CSfC-certified Data-at-Rest (DAR) Security.
Graid Technology Inc. and KLC Group Secure Groundbreaking Partnership to Disrupt High-Speed RAID and Data-at-Rest Security
At the core of this collaboration is a novel approach to data security. Combining the National Security Agency's (NSA) Commercial Solutions for Classified (CSfC) Data-at-Rest (DAR) Security guidelines, the joint solution integrates encryption, access controls, and authentication to deliver military-grade data protection. This breakthrough is designed to meet the critical needs of government contractors and organizations that require NSA CSfC-certified protection alongside high-performance RAID storage.
While CipherDriveOne Plus provides robust hardware-based full-disk encryption, traditional RAID solutions have presented challenges, including drive-locking mechanisms that limit the performance of CSfC-compliant NVMe SSDs or spinning disks. SupremeRAID™ by Graid Technology offers a groundbreaking alternative. As a GPU-accelerated software RAID, SupremeRAID™ eliminates the bottlenecks and limitations of hardware RAID, allowing CSfC-compliant systems like CipherDriveOne Plus to operate without compromising authentication processes or drive performance. This results in superior data protection and seamless NVMe SSD operation.
CipherDriveOne Plus, a Hardware Full Disk Encryption - Authorization Acquisition (AA) solution, is designed to meet the U.S. Government's strict Data-at-Rest (DAR) standards. It provides key management, encryption, and authentication over OPAL 2.0 self-encrypting SSDs or HDDs, ensuring immediate data protection that is OS-agnostic and governed by FIPS-140-2 level key encryption with options for single, two-factor, or multi-factor authentication.
"By joining forces with KLC Group, we are redefining the performance and security benchmarks in high-performance computing, AI, and diverse industries reliant on data-intensive operations," stated Leander Yu, President and CEO of Graid Technology. "The collaboration between SupremeRAID™ and CipherDriveOne Plus not only enhances performance but also ensures comprehensive data protection, scalability, and flexibility."
To explore the advanced data protection and storage performance offered by this partnership, download the solution brief.
For more information:
Graid Technology: https://www.graidtech.com/federal-and-public-sector/
KLC Group: https://klc-group.com/
CipherDriveOne: https://www.cipherdriveone.com
About KLC Group and CipherDriveOne
KLC Group is a leading provider of cybersecurity solutions, dedicated to safeguarding organizations from evolving cyber threats. With a focus on innovation and excellence, KLC Group has consistently delivered cutting-edge security solutions tailored to meet the unique needs of its clients. Learn more: www.klc-group.com
About Graid Technology and SupremeRAID™
Graid Technology is led by a dedicated team of experts with decades of experience in the SDS, ASIC, and storage industries, and continues to push boundaries in data storage innovation by protecting NVMe-based data from the desktop to the cloud. Cutting-edge SupremeRAID™ GPU-based RAID removes the traditional RAID bottleneck to deliver maximum SSD performance without consuming CPU cycles or creating throughput bottlenecks, delivering unmatched flexibility, performance, and value. With headquarters in Silicon Valley supported by a robust R&D center in Taiwan, we are globally committed to spearheading advancements in storage solutions. For detailed product information, visit our website, or connect with us on Twitter (X) or LinkedIn.
Contact Information
Andrea Eaken
Director of Marketing, Americas & EMEA | Graid Technology
andrea.eaken@graidtech.com
949-742-9928
John C. Myung
President, KLC Group
john@klc-group.com
408-614-1414
Related Files
SupremeRAID and CipherDriveOne Solution Brief_2024
SOURCE: Graid Technology Inc.
View the original press release on newswire.com.
Graid Technology Inc.

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, Starting in the Second Half of 2026 with Corresponding 2027 Revenue Target12.1.2026 14:05:00 CET | Press release
Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating revenue in the second half of 2026. Target revenue for this project is $400 to $500 million, thereby supporting the $200 million revenue guidance for 2026. With the full deployment of Datavault AI's nodes across 100+ cities throughout the United States, the 2027 revenue target is $2.0 to $3.0 billion for 2027. New York and Philadelphia edge network activation positions Datavault AI to potentially capture a significant share of the insurance and financial sectors, the healthcare industry, and enterprise opportunities. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in AI-driven data valuation, monetization, credentialing, and digital engagement technologies, today highlighted the strategic importance of its New York and Philadelphia edge network deployment with Available Infrastructure's SanQtum AI platform. This
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 13:00:00 CET | Press release
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 12:00:00 CET | Press release
SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan
Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment12.1.2026 12:00:00 CET | Press release
On January 10, 2026, a few dozen of NFL Alumni Greats (click here for a list of participating athletes) live-autographed 100 Footballs (click here to view the autographed NFL Alumni Footballs) and 500 Jerseys (click here to view the autographed NFL Alumni Jerseys); Starting on February 1, 2026, these special, one-time, live-autographed memorabilia items are to be given away by lottery to eligible holders of Dream Bowl Meme Coin I tokens and, following their distribution date (currently set for February 21, 2026), Dream Bowl Meme Coin II tokens and will be tradable on the upcoming International NIL Exchange; $25,000 E-Sports Scholarships Raised by Sponsors were Given to Dream Bowl Madden and Team E-Sports Champions; and 70 Student Star Athletes Showcased their Talent to USFL, NFL and European League Scouts (click here to view the Special Dream Bowl XIV Participants' Jerseys). PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom